Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
62%
Parkinson
28%
Levodopa-induced Dyskinesia
23%
Mild Cognitive Impairment
23%
Machine Learning
15%
Clinical Data
14%
Risk Factors
13%
Luxembourgish
13%
GBA1
12%
Dopaminergic Pathway
11%
Long-read Sequencing
11%
IL-1R1
11%
Cardiovascular History
11%
Disease Duration
11%
Prognostic Analysis
11%
Risk Variant
11%
Cross-cohort
11%
Authorship Criteria
11%
Gait Data
11%
Metabolomics Data
11%
Outcome Prediction
11%
Clinical Decision Support Tool
11%
Colorectal Cancer
11%
Patient-derived Spheroids
11%
Polygenic Background
11%
Cardiovascular Risk
11%
Xanthine Metabolism
11%
Predictors of Cognitive Impairment
11%
Therapeutic Response
11%
Idiopathic PD
11%
Gut Microbiota
11%
Memory Impairment
11%
Variant Carriers
11%
Cancer-associated Fibroblasts
11%
Idiopathic Parkinson's Disease
11%
Major Risk
11%
Metastatic Colorectal Cancer (mCRC)
11%
Health Effects
11%
Cross-sectional Observational Study
11%
Functional Profiling
11%
Post-COVID
11%
Tumor Immunosuppression
11%
Tumor Development
11%
Parkinson's Disease-mild Cognitive Impairment
7%
Fibroblasts
7%
95% Confidence Interval
6%
Luxembourg
6%
History of Cardiovascular Disease
5%
Family History
5%
Non-carriers
5%
Neuroscience
Parkinson's Disease
100%
Mild Cognitive Impairment
38%
L-DOPA
23%
Dyskinesia
23%
Gut Microbiome
23%
Risk Factor
17%
Comorbidity
15%
Progressive Supranuclear Palsy
11%
MicroRNA
11%
Memory Disorder
11%
Cognitive Disorders
11%
Gait
11%
Cardiovascular System
11%
Dopamine
11%
SARS Coronavirus
5%
Subjective Cognitive Decline
5%
Stereotypic Movement Disorder
5%
Medicine and Dentistry
Parkinson's Disease
59%
Gait
26%
Metabolomics
23%
Gut Microbiome
11%
Mild Cognitive Impairment
11%
Observational Study
11%
Treatment Response
11%
Metastatic Colorectal Cancer
11%
Tumor Spheroid
11%
Education
11%
Dopamine
11%
Levodopa-Induced Dyskinesia
11%
Cardiovascular System
11%
Comorbidity
9%
Genetics
7%
Cardiovascular Disease
6%
Stereotypic Movement Disorder
5%
Diseases
5%
Unified Parkinson's Disease Rating Scale
5%
Levodopa
5%